Admit the patient for cardiac monitoring. A simple statement, but with the technology available today, you have choices to make to provide this service effectively for your patient. With the development of technologically advanced systems, hospitals have gone far beyond simply monitoring for dysrhythmia. Systems today offer computerized dysrhythmia analysis and can check multiple leads at once, derive full 12-lead electrocardiograms (ECGs) from the standard 5-lead set-up, trend data, and monitor for ST-segment changes.
The American Heart Association has published detailed standards in response to this increased capability to monitor for complex dysrhythmias, ST-segment and QT-interval changes.1 The American College of Cardiology has developed guidelines defining which patients will benefit from cardiac monitoring.2 These organizations provide clear recommendations for best practices.
Review the criteria
Your hospital should have admission/discharge criteria set up for units that provide cardiac monitoring. A policy that defines the criteria is essential when multiple units provide cardiac monitoring.
Levels of monitoring intensity can be defined based on best-practice recommendations. The chart Cardiac monitoring criteria, which defines guidelines based on the admission diagnosis, recommends monitoring the patient for 24 to 72 hours. If the patient doesn't have a dysrhythmia, you can discontinue monitoring (let the patient's health care provider know of this decision). If the health care provider overrides the decision, document in the patient's medical record the justification for the ongoing procedure. Establishing well-defined criteria, including removing from cardiac monitoring patients who'll no longer benefit from the service, helps prevent the backlog that so often occurs in emergency departments as patients wait for beds in telemetry units and progressive care units.
Monitoring: Best practice
The American Association of Critical-Care Nurses (AACN) has published two practice alerts to define the best practices for monitoring patients for dysrhythmia and ST-segment changes.3,4 Simply placing a monitor on the patient, using a standard lead, and waiting for an alarm isn't enough. When a patient is admitted for cardiac monitoring, ask yourself these questions: Should I be concerned about QT prolongation? Is there a potential for ischemia? Should I monitor ST segments? Which leads should I be using to watch for ST-segment changes?
To prepare the patient for cardiac monitoring, adhere to the following steps (or those mandated by your facility):
1. Verify the order for telemetry monitoring.
2. Provide preprocedure education with verification of patient and family understanding.
3. Assess the patient.
4. Assess the patient's history for cardiac dysrhythmias or other cardiac problems. Is he being monitored for ischemia or dysrhythmia, or both? Plan what lead you'll need to use.
5. Properly prepare the patient's skin before attaching the electrodes. Preparation may include clipping hair from areas where electrodes will be placed, performing mild abrasion of the skin with a washcloth, using a scratch pad on the electrode pad or gauze pad, and cleaning the skin with alcohol to remove skin oils.
6. Properly place leads on the patient. Accurate lead placement is critical for precise diagnosis. Consistent lead placement is also important because ECG information obtained from electrodes located close to the heart (precordial leads) is especially prone to waveform changes when the electrodes are removed and replaced as much as 1 cm from their original position. Mark the location of the leads with a single patient-use skin marker to assure correct replacement.5
Monitoring for dysrhythmia and ischemia
The best dysrhythmia monitoring lead is V1; the next best is V6 (their bipolar equivalents are MCL1 and MCL6).4 Rhythms that can be distinguished in V1 but not in other leads include those with a widened QRS complex, such as right versus left ventricular rhythms; right and left bundle branch blocks; and differentiation of supraventricular rhythms with aberration from ventricular rhythms. Also, P waves are often visible in V1 when they're invisible in other leads because the exploring electrode is the one closest to the atria.
Select the monitoring lead based on the patient's dysrhythmia.
* Use lead V1 to distinguish ventricular from supraventricular rhythms with aberrant conduction.
* Use lead II or lead III to monitor atrial activity (atrial fibrillation and atrial flutter). If P waves are poorly visualized, use V1.
* Use lead V1 for primary monitoring if there's no history of or potential for atrial dysrhythmias and for patients with pacemakers.
Follow these guidelines when monitoring the patient:
* Monitor the QT interval for patients at high risk for torsades de pointes.
* Monitor patients who were started on antiarrhythmic drugs known to cause torsades de pointes (quinidine, procainamide, disopyramide, sotalol, ibutilide).
* Watch for adverse reactions to potentially proarrhythmic drugs.
* Watch for new onset bradycardias.
* Monitor the patient's serum potassium and magnesium levels for severe hypokalemia or hypomagnesemia.
It's now possible to monitor for ST-segment changes in patients with a potential for myocardial ischemia. This patient may be admitted with unstable angina or chest pain, or be a postoperative patient with a history of heart disease. ST-segment monitoring is also used for patients after cardiac interventions. This modality can alert you to any reocclusion of the target vessels.
Cardiac monitoring allows the detection of ST-segment changes at the start of ischemic events. Prompt intervention will prevent the development of injury and infarction. The AACN recommends leads III and V3 for ST-segment monitoring in patients with acute coronary syndromes.4 Remain aware of the following segment changes:
* T-wave inversion, alone or with ST-segment depression: A symmetrical arrowhead T-wave inversion in a lead that normally has an upright T wave is a hallmark of ischemia.
* ST-segment depression: This pattern is often seen in combination with a sharp angle at the junction of the ST segment and the T wave, indicating ischemia.
The hardest decision with these patients is to determine which lead to monitor. The wrong choice here will result in missing an evolving event. One could be watching lead II, which is frequently chosen for dysrhythmia detection, and miss ischemia in the right coronary artery, which will be viewed in leads III and aVF. The choice of which lead to monitor is a crucial nursing decision.
In the ideal situation, the patient has evidence of prior ischemia and you can define the patient's ischemic "fingerprint." The ischemic fingerprint is the unique pattern of ST-segment changes noted during a period of ischemia.6 This pattern may be observed during an episode of chest pain or with balloon inflation during angioplasty. Record which ECG lead demonstrates the most significant changes and give that information to the nurse who'll initiate monitoring.
If you don't know the patient's fingerprint, AACN recommends monitoring in leads III and V3.4 If you have an idea which vessels are involved, you can consult an ECG lead chart to make the decision. (See What's my lead?)
Monitoring the ST segment can be challenging. A baseline must be established with the patient in a supine position. Movement and position changes will cause ST-segment variations and occasional alarms. The trick is to set the alarm parameters accurately and monitor for trends in the ST segment. When alarms occur, it may be nothing if the patient is ambulating. When the trend is checked, no overall ST-segment change is evident. In cases in which the ischemia is real, checking the ST-segment trend will demonstrate a change in the ST segment overall.
Advances in technology and a large body of research have greatly enhanced our ability to monitor patients for dysrhythmia and ischemia. As a critical care nurse, you must determine the best way to monitor the patient: Which leads are best and what is the purpose for monitoring (dysrhythmia, ST segment, QT interval). Making the right decisions can lead to efficient diagnosis and treatment and better patient outcomes.
|Table. No caption available.|
Cardiac monitoring criteria
Patients with these conditions should be monitored for 24 to 48 hours:
* Low probability of myocardial infarction (MI), to rule out MI
* Any hemodynamically stable dysrhythmia
* Before and after coronary angiography in patients with stable angina and no heart failure
* Cardiac contusion without hemodynamic instability
* Neurologic changes such as transient ischemic attack or stroke
* Acute medical illness with stable cardiac disease and no ischemia
* Mild heart failure without shock (Killip Class I)
* Postoperative surgery patients with cardiac history but no active ischemia
* Post-permanent pacemaker placement
* Overdose or drug toxicity without dysrhythmia
* Syncope in patients without heart failure or respiratory failure
Patients with these conditions should be monitored for 48 to 72 hours:
* Unstable angina: rule out myocardial infarction
* Hemodynamically stable myocardial infarction
* Any hemodynamically unstable dysrhythmia, not including potentially lethal dysrhythmias that require continuous cardiac monitoring
* Before and after percutaneous coronary intervention in stable patients
* During initiation of type I or type III antiarrhythmia agents for dysrhythmias
* Major ischemic or hemorrhagic stroke with potential for dysrhythmia
* Acute medical illness with cardiac disease
* Moderate heart failure without shock (Killip Class II)
* Postoperative surgery in patients with angina, ST-segment and T-wave changes, myocardial ischemia on preoperative stress test, dysrhythmia, hypotension, or heart failure
* Respiratory failure as defined by hypoxemia, hypercapnea, uncompensated respiratory acidosis with pH less than 7.35, clinical evidence of severe respiratory distress
* Overdose or drug toxicity with dysrhythmia or high potential for dysrhythmia
* Syncope in patients with heart failure or respiratory failure
* History of status epilepticus or seizure disorder and risk for sudden death
1. Drew BJ, Funk M. AHA scientific statement: Practice standards for electrocardiographic monitoring in hospital settings. Journal of Cardiovascular Nursing. 20(2):76-106, March/April 2005. [Context Link]
2. American College of Cardiology. Position statement: Recommended guidelines for in-hospital cardiac monitoring of adults for detection of dysrhythmia. Journal of the American College of Cardiology. 18(6):1431-1433, November 1991. http://www.acc.org/qualityandscience/clinical/position/72535.htm. Accessed June 12, 2006. [Context Link]
3. American Association of Critical-Care Nurses. Nursing practice alert: Dysrhythmia monitoring. http://www.aacn.org/AACN/practiceAlert.nsf/Files/DM%20PDF/$file/Dysrhythmia%20Mo. Accessed June 12, 2006. [Context Link]
4. American Association of Critical-Care Nurses. Nursing practice alert: ST segment monitoring. http://www.aacn.org/AACN/practiceAlert.nsf/Files/STSM/$file/ST%20Segment%20Monit. Accessed June 12, 2006. [Context Link]
5. Clochesy JM, Cifani L, Howe K. Electrode site preparation techniques: A follow-up study. Heart & Lung. 20(1):27-30, January 1991. [Context Link]
6. Drew BJ. Celebrating the 100th birthday of the electrocardiogram: Lessons learned from research in cardiac monitoring. American Journal of Critical Care. 11(4):378-388, July 2002. [Context Link]